Work

Brentuximab vedotin activity in diffuse large B-cell lymphoma with CD30 undetectable by visual assessment of conventional immunohistochemistry

Year: 2016

Type: article

Source: Leukemia & lymphoma/Leukemia and lymphoma

DOI: 10.1080/10428194.2016.1256481

Authors: Nancy L. Bartlett, Mitchell R. Smith, Tanya Siddiqi, Ranjana H. Advani, Owen A. O’Connor, Jeff P. Sharman, Tatyana Feldman, Kerry J. Savage, Andrei R. Shustov, Catherine S. Diefenbach, Yasuhiro Oki, Maria Corinna Palanca-Wessels, Mayur Uttarwar, Martha Li, Jing Yang, Eric D. Jacobsen

Institutions: Washington University in St. Louis, Cleveland Clinic, City Of Hope National Medical Center, Stanford Medicine, NewYork–Presbyterian Hospital, Columbia University Irving Medical Center, Willamette Valley Cancer Institute and Research Center, Hackensack University Medical Center, BC Cancer Agency, Seattle Cancer Care Alliance, University of Washington Medical Center, NYU Langone Health, The University of Texas MD Anderson Cancer Center, Seagen (United States), Dana-Farber Cancer Institute

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2551804989

FWCI: 4.688

Cites: 32

Cited by: 61

Related to: 10